The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIOMED INC | COM | 003654100 | 318,835 | 708,917 | SH | SOLE | 708,917 | 0 | 0 | ||
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 34,964 | 1,684,180 | SH | SOLE | 1,684,180 | 0 | 0 | ||
AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 37,694 | 1,381,759 | SH | SOLE | 1,381,759 | 0 | 0 | ||
ALDER BIOPHARMACEUTICALS INC | COM | 014339105 | 30,854 | 1,853,101 | SH | SOLE | 1,853,101 | 0 | 0 | ||
ALEXION PHARMACEUTICALS INC | COM | 015351109 | 166,840 | 1,200,201 | SH | SOLE | 1,200,201 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 57,825 | 147,807 | SH | SOLE | 147,807 | 0 | 0 | ||
ALIMERA SCIENCES INC | COM | 016259103 | 2,954 | 3,013,793 | SH | SOLE | 3,013,793 | 0 | 0 | ||
AMAG PHARMACEUTICALS INC | COM | 00163U106 | 67,610 | 3,380,506 | SH | SOLE | 3,380,506 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 76,967 | 6,366,147 | SH | SOLE | 6,366,147 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 247,218 | 2,549,431 | SH | SOLE | 2,549,431 | 0 | 0 | ||
CELGENE CORP | COM | 151020104 | 38,415 | 429,267 | SH | SOLE | 429,267 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 153,342 | 5,221,026 | SH | SOLE | 5,221,026 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,218 | 123,686 | SH | SOLE | 123,686 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 7,644 | 500,913 | SH | SOLE | 500,913 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 73,205 | 6,906,158 | SH | SOLE | 6,906,158 | 0 | 0 | ||
EXACT SCIENCES CORP | COM | 30063P105 | 24,727 | 313,320 | SH | SOLE | 313,320 | 0 | 0 | ||
GILEAD SCIENCES INC | COM | 375558103 | 13,581 | 175,900 | SH | SOLE | 175,900 | 0 | 0 | ||
HISTOGENICS CORP | COM | 43358V109 | 165 | 302,922 | SH | SOLE | 302,922 | 0 | 0 | ||
IDERA PHARMACEUTICALS INC | COM PAR | 45168K405 | 686 | 77,044 | SH | SOLE | 77,044 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 104,437 | 5,013,764 | SH | SOLE | 5,013,764 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 148,764 | 7,357,283 | SH | SOLE | 7,357,283 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 79,416 | 4,663,324 | SH | SOLE | 4,663,324 | 0 | 0 | ||
MELINTA THERAPEUTICS INC | COM | 58549G100 | 200 | 50,689 | SH | SOLE | 50,689 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 48,222 | 1,833,532 | SH | SOLE | 1,833,532 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 14,431 | 1,103,325 | SH | SOLE | 1,103,325 | 0 | 0 | ||
RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 12,731 | 3,966,087 | SH | SOLE | 3,966,087 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 118,703 | 840,372 | SH | SOLE | 840,372 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 34,938 | 192,738 | SH | SOLE | 192,738 | 0 | 0 | ||
SOPHIRIS BIO INC | COM NEW | 83578Q209 | 689 | 247,000 | SH | SOLE | 247,000 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 169,035 | 3,521,565 | SH | SOLE | 3,521,565 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,325 | 1,162,473 | SH | SOLE | 1,162,473 | 0 | 0 | ||
TREVENA INC | COM | 89532E109 | 724 | 341,300 | SH | SOLE | 341,300 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 207,835 | 1,625,234 | SH | SOLE | 1,625,234 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 95,373 | 4,155,670 | SH | SOLE | 4,155,670 | 0 | 0 | ||
WRIGHT MED GROUP N V | ORD SHS 0.03 PAR | N96617118 | 80,025 | 2,757,587 | SH | SOLE | 2,757,587 | 0 | 0 | ||
ZOGENIX INC | COM NEW | 98978L204 | 1,463 | 29,500 | SH | SOLE | 29,500 | 0 | 0 |